A Comparison between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study
Table 1
Prevalence of metabolic syndrome by IDF and revised NCEP ATP III definitions by gender and age groups.
IDF
Revised NCEP ATP III
% (95% CI)
% (95% CI)
Total
2985
38.9 (37.18–40.67)
46.1 (45.8–46.4)
Women
1627
45.8 (43.38–48.22)
56.1 (55.8–56.5)
Men
1358
22.9 (20.72–25.19)
33.9 (33.6–34.2)
Age (years)
Women
35–44 yrs
274
37.0 (31.30–42.70)
44.2 (38.3–50.0)
45–54 yrs
630
50.9 (47.14–54.88)
58.6 (54.8–62.4)
55–65 yrs
723
55.5 (52.38–65.45)
65.7 (62.2–69.1)
Men
35–44 yrs
241
17.8 (13.39–23.06)
29.8 (24.0–35.6)
45–54 yrs
509
26.5 (23.20–30.96)
34.9 (30.8–39.1)
55–65 yrs
608
27.9 (24.50–31.63)
36.9 (33.0–40.7)
CI: Confidence interval. Prevalences have been adjusted for the Ragama population using equal weights for each group in each gender.
